Proteomic identification of nitrated brain proteins in early Alzheimer's disease inferior parietal lobule - Wikidata - wikimedia - TriplyDB

Proteomic identification of nitrated brain proteins in early Alzheimer's disease inferior parietal lobule

Proteomic identification of nitrated brain proteins in early Alzheimer's disease inferior parietal lobule

http://www.wikidata.org/entity/Q33643522

about

Getting to NO Alzheimer's Disease: Neuroprotection versus Neurotoxicity Mediated by Nitric Oxide Recent advances in quantitative neuroproteomics Peroxiredoxins: guardians against oxidative stress and modulators of peroxide signaling Abeta, oxidative stress in Alzheimer disease: evidence based on proteomics studies Multiple Forms of Glutamate Dehydrogenase in Animals: Structural Determinants and Physiological Implications Insight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profiling Proteomics of protein post-translational modifications implicated in neurodegeneration Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease.Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.Oxidative stress and mitochondrial dysfunction in Alzheimer's disease.The Role of Interleukin-18, Oxidative Stress and Metabolic Syndrome in Alzheimer's Disease.Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics.Interleukin-18 alters protein expressions of neurodegenerative diseases-linked proteins in human SH-SY5Y neuron-like cells Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegeneration Nitration transforms a sensitive peroxiredoxin 2 into a more active and robust peroxidase.Synergistic Interaction of Light Alcohol Administration in the Presence of Mild Iron Overload in a Mouse Model of Liver Injury: Involvement of Triosephosphate Isomerase Nitration and Inactivation Oxidative stress and lipid peroxidation are upstream of amyloid pathology.Altered intrinsic regional spontaneous brain activity in patients with optic neuritis: a resting-state functional magnetic resonance imaging study ANSID: A Solid-Phase Proteomic Approach for Identification and Relative Quantification of Aromatic Nitration Sites Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression.Interaction of aldehydes derived from lipid peroxidation and membrane proteins Dietary vitamin D deficiency in rats from middle to old age leads to elevated tyrosine nitration and proteomics changes in levels of key proteins in brain: implications for low vitamin D-dependent age-related cognitive decline.Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism.Basic mechanisms of neurodegeneration: a critical update.Proteomic analysis of mitochondrial dysfunction in neurodegenerative diseases.Pharmacologists and Alzheimer disease therapy: to boldly go where no scientist has gone before.Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain.Mass spectrometric analysis of protein tyrosine nitration in aging and neurodegenerative diseases.Mass spectrometry and redox proteomics: applications in disease.Lipid peroxidation and tyrosine nitration in traumatic brain injury: Insights into secondary injury from redox proteomics.The Application of Proteomics to Traumatic Brain and Spinal Cord Injuries.Alterations in brain antioxidant enzymes and redox proteomic identification of oxidized brain proteins induced by the anti-cancer drug adriamycin: implications for oxidative stress-mediated chemobrain.Angiotensin-converting enzyme inhibition curbs tyrosine nitration of mitochondrial proteins in the renal cortex during the early stage of diabetes mellitus in rats.Redox regulation of cysteine-dependent enzymes in neurodegeneration.Proteomic analysis of brain proteins in APP/PS-1 human double mutant knock-in mice with increasing amyloid β-peptide deposition: insights into the effects of in vivo treatment with N-acetylcysteine as a potential therapeutic intervention in mild cog In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid beta-peptide of APP.Isatin-binding proteins of rat and mouse brain: proteomic identification and optical biosensor validation.Redox proteomics: from protein modifications to cellular dysfunction and disease.Isatin, an endogenous nonpeptide biofactor: A review of its molecular targets, mechanisms of actions, and their biomedical implications.Oxidative Stress, Amyloid-β Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer's Disease.

P2860

Q26772294-E022DBE1-3281-4E20-BC0A-15976BF58B12 Q27000073-B101E5B7-FD1D-4E7B-B34D-8F2DF26C5435 Q27026271-10BE5365-3AA0-44E2-8794-B2AE171351C2 Q27693922-28FEC3B5-BB54-4323-A803-2CFFE7F7D9B5 Q28074448-81223D46-08B1-4464-BBFD-1AE55FF1DEA9 Q28076999-77B07CFD-496C-49D3-97C7-D01BE4FC2A83 Q28088631-535CD92D-D619-4EDE-9F58-D3F6BE7196B5 Q30394816-5ACB8F16-BB10-47D0-A3A7-9CB6973BA906 Q30446460-7DCAF8F3-E0BF-4725-8851-4213F3DFFA85 Q33555956-CD1B5FF3-0C83-4FF4-B200-0EB46F158A1C Q33737263-77D09B8F-2F0C-4221-9EBF-CB2726CD5045 Q33912803-CDD6AAF5-A504-4E89-B282-BA4E5AF1413D Q34014666-04CC3C2B-629F-4F77-89AB-B56C85F1EB7E Q34071097-75C55EDC-051E-45A0-8CDC-E2BCA37157DE Q34075973-C3112246-C058-4F44-A808-48F8E6FA89C9 Q36253995-7A9DE0FA-1D1B-4560-9243-35C3E5DBE87A Q36387084-D645BB21-D8B7-4CCA-BA92-6F54A707D01C Q36390994-B7F06F43-CAE8-4EA9-A82B-95A1900A0CDD Q36437754-B0DA25B6-35F3-4782-9C37-354701275310 Q37111515-FFD88930-C5EE-4B62-A688-F5D3B159E47B Q37142547-57C80CA9-8055-4DE1-AAAD-9DC3535CA35A Q37384973-F12931E4-083D-4F5D-AB68-C349923BF95E Q37603401-E091E658-1F09-4B0B-8BDE-AE2B3E60507A Q37673274-BAFCF4EF-5D94-4A3C-A376-CA2DFC24F611 Q37775036-33FA483E-DEE9-40A7-BB7D-30AD89B265E8 Q37910243-C1CF1913-8C2E-420C-8A63-DA11C0EC74C7 Q38050263-2B8F7853-0E73-4B75-A62C-ABAB4051AE5D Q38217025-EA0291F8-8C79-4A54-AA58-5C4CA7BCF11A Q38220377-180F860F-9592-4362-9782-01F076042778 Q38824992-0FDAA18D-B477-446A-A730-175234DCDFE9 Q39173777-00A2D2DA-F5E6-4A03-9EE6-E51D8CD2521C Q39981865-EAC14F37-7F32-46F0-BDAE-FF6DD7E1B52A Q42104057-78286A72-4E48-49C7-A5B6-90A4128D2B34 Q42239663-597AB692-396C-46A6-AFBF-631CA56FBBA3 Q42397173-0B4D1C04-AC89-4DD7-BA1C-478C0FE9319F Q42920869-0487ADB2-89ED-43E9-9697-8C7FFFD160B6 Q43260288-906AE290-1B16-4648-8BC7-9BEE8A917F3A Q46966345-24B0A0A4-1861-422E-8981-CAAF3D566213 Q47863261-A2B180ED-AF66-4616-A40D-661FC0CFA5B3 Q51760895-B7127616-A577-4FC1-96A0-EBFB6DC96AFC

P2860

Proteomic identification of nitrated brain proteins in early Alzheimer's disease inferior parietal lobule

http://www.wikidata.org/entity/Q33643522

description

2008 nî lūn-bûn

@nan

2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Proteomic identification of ni ...... sease inferior parietal lobule

@ast

Proteomic identification of ni ...... sease inferior parietal lobule

@en

type

label

Proteomic identification of ni ...... sease inferior parietal lobule

@ast

Proteomic identification of ni ...... sease inferior parietal lobule

@en

prefLabel

Proteomic identification of ni ...... sease inferior parietal lobule

@ast

Proteomic identification of ni ...... sease inferior parietal lobule

@en

P1433

Q33643522-BEB7D648-267F-44D4-AD9F-1F42C69752BC

P1476

Q33643522-E9C6F8DF-120F-4B71-B0D0-D74FBA923024

P2093

Q33643522-5627C4D4-5993-4DD7-9FD9-A4E1C87E84BC

Q33643522-8DB1B4E5-9111-4573-BB78-213E5EAE5924

Q33643522-BEB8B00D-3001-4929-9CC4-B63AF472DDE9

Q33643522-D1A6E2BB-79BF-4185-A6CB-A28211115070

P2860

Q33643522-035EEA43-FB62-44CC-B87C-B7F1D9BBE500

Q33643522-06C2891C-4B4C-4E04-A8A2-DBFF71F3C4E0

Q33643522-08BEEDD5-B17E-4F11-87F3-29787EFACB70

Q33643522-1EA384B4-8561-4AB0-8469-0D3B623304C7

Q33643522-21E7234E-7081-43A5-B388-503943A0C945

Q33643522-2889A58E-6C52-4A63-AE91-5A554F308563

Q33643522-2A7204F9-AC37-4024-A1DA-11A3999C8D57

Q33643522-36F26ECC-B02B-4210-A7FC-19C0EEF2DD7D

Q33643522-395B2C15-020B-45B3-AFC6-7CD9DBBC4AEE

Q33643522-425CC6E4-6215-4C50-A437-3621B86BD69C

P304

Q33643522-067848D3-EBE9-493E-A6C6-AA2B7E6D255B

P31

Q33643522-42DB0E82-78F6-4FD2-965E-30C9CCB22358

P356

Q33643522-0349259B-9A7B-4BDC-983D-FA6EFAA36A0A

P433

Q33643522-41269A8B-A2B6-4312-9722-261B251C4A48

P478

Q33643522-8C50F35C-5073-4BDC-AC60-A106825911E1

P50

Q33643522-9A256DA5-D69B-4069-A83E-EB8D96E543F0

P577

Q33643522-B6E47C92-56EC-4143-8478-DD446568B26D

P5875

Q33643522-F152FD69-B742-4A48-A2BF-5A75734897FC

P698

Q33643522-8854D8E2-ADC4-429D-9469-8DA0974911C0

P921

Q33643522-85226988-577C-4F76-9F96-C87011E0260A

P932

Q33643522-E0F9CA60-6C38-4245-8C5D-CE40DBA655D5

P356

J.1582-4934.2008.00478.X

P1433

Journal of Cellular and Molecular Medicine

P1476

Proteomic identification of ni ...... sease inferior parietal lobule

@en

P2093

Delano M Turner

http://www.w3.org/2001/XMLSchema#string

Tanea T Reed

http://www.w3.org/2001/XMLSchema#string

William M Pierce

http://www.w3.org/2001/XMLSchema#string

William R Markesbery

http://www.w3.org/2001/XMLSchema#string

P2860

Mild Cognitive Impairment Can Be Distinguished From Alzheimer Disease and Normal Aging for Clinical Trials

Human aldolase A deficiency associated with a hemolytic anemia: thermolabile aldolase due to a single base mutation

Neuropathological stageing of Alzheimer-related changes

Association of ATP synthase alpha-chain with neurofibrillary degeneration in Alzheimer's disease

Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders

Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down syndrome

Adriamycin-mediated nitration of manganese superoxide dismutase in the central nervous system: insight into the mechanism of chemobrain

Murine thioredoxin peroxidase delays neuronal apoptosis and is expressed in areas of the brain most susceptible to hypoxic and ischemic injury

Controlled elimination of intracellular H(2)O(2): regulation of peroxiredoxin, catalase, and glutathione peroxidase via post-translational modification.

Protein nitration in a mouse model of familial amyotrophic lateral sclerosis: possible multifunctional role in the pathogenesis.

P304

2019-2029

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1582-4934.2008.00478.X

http://www.w3.org/2001/XMLSchema#string

P433

8B

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

D Allan Butterfield

P577

2008-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23219257

http://www.w3.org/2001/XMLSchema#string

P698

18752637

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2819643

http://www.w3.org/2001/XMLSchema#string